Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Senate votes to appeal Obamacare Cadillac tax

The Senate voted 90-10 to repeal Obamacare’s “Cadillac tax” on high-cost health plans, a rare instance of bipartisanship around the contentious healthcare law. 

Why did 11% of organizations call ICD-10 transition a 'failure'?

Another survey indicates that the Oct. 1 transition to ICD-10 went smoothly for most healthcare providers, but 11 percent said it was a failure, according to KPMG. 

Thumbnail

For-profit players have a place in universal healthcare systems: Canadian study

In a study of healthcare systems in six developed nations that could have implications for the U.S.—regardless of the ultimate fate of troubled Obamacare—an influential Canadian think tank has concluded that for-profit hospitals and insurers can survive and thrive under universal health care.

CMS clarifies actions regarding ICD-10 claims problems

Overall, there have been few complaints in the wake of the transition to ICD-10 but a few isolated incidents have led the Centers for Medicare & Medicaid Services (CMS) to issue clarifications on how it's resolving the issues.

Thumbnail

CHIME: Streamline MU, add flexibility

Meaningful Use (MU) needs streamlining and a reduced reporting burden for provider through better aligned quality measures, said the College of Healthcare Information Management Executives (CHIME). 

Thumbnail

Coder productivity down in wake of ICD-10 transition

As critics predicted, the ICD-10 transition is negatively impacting inpatient and outpatient coder productivity at hospitals of all sizes and types.

Health system announces new plan to refund patients if expectations aren't met

The Pennsylvania-based Geisinger Health System has unveiled its ProvenExperience program, which offers refunds to patients who don’t have their expectations met while receiving care. 

Healthcare leaders spanning the globe urge U.S. presidential hopefuls to back openness on clinical trials

Close to 60 physicians, medical researchers and public-health experts from around the world are imploring American presidential candidates to state whether they support access to all clinical trial data held by U.S. federal agencies—regardless of the trials’ topics, findings, sponsors or geographical settings. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.